Adverse Event Web-based Seminars
Adverse Event Training Provider? - Tell us about your Training!
From GlobalCompliancePanel
Adverse Event Reporting for Dietary Supplements and OTC Drugs - Webinar By GlobalCompliancePanel
Since passage of the Dietary Supplement & Nonprescription Drug Consumer Protection Act in Dec. 2007, FDA requires reporting of serious adverse events for dietary supplements and OTC drugs.
Manufacturers and importers of products in these categories often have questions about what constitutes a serious adverse event and about Adverse Event reporting requirements that this Webinar will be able to
more...
Recalls Vigilance - When to Report Complaints - Webinar By GlobalCompliancePanel
...quaint one with the lessons learned from over 30 years of adverse events and complaints.
FDA has issued warning letters for failing to properly evaluate medical device complaints for reporting under 803 & 806 regulations. Vigilance reporting is also required in Canada, the European Union and many other countries. Warning letters and recalls are posted on FDA's website and published in trade
more...
Webinar on Pharmacovigilance Audit - Webinar by GlobalCompliancePanel
This webinar will describe how to conduct a thorough drug safety and pharmacovigilance audit, including compliance with applicable worldwide laws, regulations and guidance. In addition, attendees will learn how to compare the company's pharmacovigilance operations to applicable best practices.
The course will cover all aspects of drug safety and pharmacovigilance compliance including the
more...
FDAs Update on Medical Device Labeling Changes - Webinar by GlobalCompliancePanel
FDA recently released a final rule regarding the parameters in which a device manufacturer can modify label changes to a product.
Specifically, manufacturers can add or strengthen the contraindications, warnings, precautions or adverse reactions sections of labeling via a PMA supplement without prior FDA approval only when such modifications are based on newly acquired information and evidence
more...
